WallStSmart

Cosmos Health Inc. (COSM)vsMcKesson Corporation (MCK)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

McKesson Corporation generates 557331% more annual revenue ($410.98B vs $73.73M). MCK leads profitability with a 1.1% profit margin vs -33.1%. MCK earns a higher WallStSmart Score of 43/100 (D).

COSM

Hold

36

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 5.0Quality: 4.5
Piotroski: 4/9Altman Z: -2.45

MCK

Hold

43

out of 100

Grade: D

Growth: 5.3Profit: 4.5Value: 4.0Quality: 7.0
Piotroski: 5/9Altman Z: 5.40
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for COSM.

MCKSignificantly Overvalued (-60.2%)

Margin of Safety

-60.2%

Fair Value

$595.07

Current Price

$866.64

$271.57 premium

UndervaluedFair: $595.07Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COSM2 strengths · Avg: 9.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
28.8%8/10

Revenue surging 28.8% year-over-year

MCK3 strengths · Avg: 9.7/10
Debt/EquityHealth
-2.7610/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
5.4010/10

Safe zone — low bankruptcy risk

Market CapQuality
$102.66B9/10

Large-cap with strong market position

Areas to Watch

COSM4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$40.92M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-106.6%2/10

ROE of -106.6% — below average capital efficiency

Free Cash FlowQuality
$-1.78M2/10

Negative free cash flow — burning cash

MCK4 concerns · Avg: 3.3/10
PEG RatioValuation
1.684/10

Expensive relative to growth rate

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
1.1%3/10

1.1% margin — thin

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : COSM

The strongest argument for COSM centers on Price/Book, Revenue Growth. Revenue growth of 28.8% demonstrates continued momentum.

Bull Case : MCK

The strongest argument for MCK centers on Debt/Equity, Altman Z-Score, Market Cap.

Bear Case : COSM

The primary concerns for COSM are EPS Growth, Market Cap, Return on Equity.

Bear Case : MCK

The primary concerns for MCK are PEG Ratio, Return on Equity, Profit Margin. Thin 1.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

COSM profiles as a growth stock while MCK is a value play — different risk/reward profiles.

COSM carries more volatility with a beta of 4.17 — expect wider price swings.

COSM is growing revenue faster at 28.8% — sustainability is the question.

COSM generates stronger free cash flow (-2M), providing more financial flexibility.

Bottom Line

MCK scores higher overall (43/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cosmos Health Inc.

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.

McKesson Corporation

HEALTHCARE · MEDICAL DISTRIBUTION · USA

McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

Visit Website →

Want to dig deeper into these stocks?